Dr Nikhil Pathi
Qualification: DNB Medical Oncology)
Experience: 5+ Years
Areas of Specialization:
Adult Solid malignancies, Lymphomas, Precision medicine, Immunotherapy, Metronomic therapy, palliative care
a. Prathibha awardee for state-level excellence in matriculation passing exam.
b. Blue ribbon (Gold) for the best outgoing student in MBBS (2005-2011 batch).
c. Awarded 11 Gold medals during MBBS passing exams (First to Final Year).
d. Best outgoing ﬁnal medical student (Gold) from Andhra Pradesh Medical Council(2011).
e. Certiﬁcate of appreciation as Best outgoing Post Graduate by Govt of Telangana Medical and Health department(2012-2015).
f. Selected for iCMLf Preceptorship Programme 2020 at Bologna, Italy
a) Carcinoma of gall bladder: Demographic and clinicopathological proﬁle in Indian patients. Oncol J India 2018;2:3-6.
b) Clinicopathological proﬁle of anaplastic lymphoma kinase-positive nonsmall cell lung cancer: An Indian perspective. Indian Journal of Med Paediatr Oncol 2018;39:32-5.
c) Microsatellite instability in stage II and III colorectal cancer: Patterns and proﬁle. Indian Journal of Med Paediatr Oncol 2018;39:36-41.
d) Clinical proﬁle, prognostication, and treatment outcomes in non-Hodgkins lymphoma. Int J Adv Med 2017; Aug; 4(4):1184-1188. Pathi N, Viswanath S, Rathore A.
e) Receptor tyrosine kinase signaling pathways: a review. International Journal of Advances in Medicine. Pathi N et al. Int J Adv Med 2016 Nov; 3(4): 783-789
f) Cytogenetics in Myeloma-Indian Scenario at Indian Myeloma congress 2018.
g) BRCA 1 and 2 mutations in carcinoma breast: An Indian study. Rathore A, Nikhil P et al. Clin Cancer Investig J 2018;7:97-103.
h) A clinico‑epidemiological, pathological, and molecular study of lung cancer in Northwestern India. J Can Res Ther 0;0:0.
i) BRCA ness Signature in Cancers.